National Healthcare (NHC) Price to Sales (2010 - 2026)

National Healthcare (NHC) has reported Price to Sales for 17 consecutive years, with 8.11 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales rose 83.38% year-over-year to 8.11; the trailing twelve-month figure through Jun 2026 stood at 2.12 (up 86.67% YoY), and the FY2025 full-year result was 1.4, up 10.4% from the prior year.
• Price to Sales advanced to 8.11 in Q2 2026 per NHC's latest filing, from 6.53 in the prior quarter.
• Across five years, Price to Sales topped out at 8.11 in Q2 2026 and bottomed at 3.3 in Q1 2023.
• Historically, Price to Sales has averaged 4.65 across 5 years, with a median of 4.46 in 2025.
• The sharpest annual moves came in 2025 and 2026: Price to Sales retreated 21.59% in 2025, then soared 83.38% in 2026.
• Over 5 years, Price to Sales stood at 3.45 in 2022, then jumped by 36.5% to 4.71 in 2023, then declined by 4.57% to 4.5 in 2024, then climbed by 22.48% to 5.51 in 2025, then soared by 47.22% to 8.11 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 8.11, 6.53, and 5.51 for Q2 2026, Q1 2026, and Q4 2025 respectively.